← Back to Search

Probiotics for Childhood Constipation

N/A
Recruiting
Led By Susana D Collazo, MD
Research Sponsored by Connecticut Children's Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1-28 days of study period

Summary

This trial is testing if adding probiotics to standard treatment helps children with severe constipation feel better faster. Probiotics are good bacteria that can improve digestion and reduce stomach pain. Probiotics have been studied for their potential to alleviate constipation and abdominal pain in children, but the evidence is inconsistent.

Who is the study for?
This trial is for children aged 6 months to 8 years who are experiencing acute constipation and have had fewer than three bowel movements in the past week. They must be able to communicate in English or Spanish, have a working email, and not have chronic medical conditions like IBD or thyroid disorders.
What is being tested?
The study tests if adding Culturelle Probiotic + Fiber to standard treatment helps kids recover faster from acute constipation compared to a placebo. It measures time to normal stool frequency, days with abdominal pain, and return to normal eating/drinking.
What are the potential side effects?
While probiotics are generally considered safe, potential side effects may include mild digestive symptoms such as gas or bloating. However, specific side effects related to this trial's intervention will be monitored.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1-28 days of study period
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1-28 days of study period for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Time to normal frequency of stool after onset of constipation
Secondary study objectives
Improvement in abdominal pain

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: ProbioticExperimental Treatment1 Intervention
Participants in this study arm will be receiving a 28-day supply of probiotic.
Group II: PlaceboPlacebo Group1 Intervention
Participants in this study arm will be receiving a 28-day supply of placebo.

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Probiotics are live microorganisms that help restore the balance of gut microbiota, which is crucial for improving bowel regularity and stool consistency. For constipation patients, an imbalanced gut microbiota can result in slower intestinal transit and harder stools. By enhancing the gut microbiota, probiotics can alleviate constipation symptoms, making bowel movements more regular and less painful.

Find a Location

Who is running the clinical trial?

Connecticut Children's Medical CenterLead Sponsor
73 Previous Clinical Trials
26,324 Total Patients Enrolled
Susana D Collazo, MDPrincipal InvestigatorConnecticut Children's Medical Center

Media Library

Placebo Clinical Trial Eligibility Overview. Trial Name: NCT05734833 — N/A
Constipation Research Study Groups: Probiotic, Placebo
Constipation Clinical Trial 2023: Placebo Highlights & Side Effects. Trial Name: NCT05734833 — N/A
Placebo 2023 Treatment Timeline for Medical Study. Trial Name: NCT05734833 — N/A
~103 spots leftby Sep 2025